Beginnings of Personalized Medicine for Myeloma

Ajai Chari, MD

Video Categories: Personalized Medicine

Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.
January 20, 2016

Which Stem Cell Properties Drive Which Cancers?

Dr Wainberg and Dr Gerson review the characteristics of these stem cells, what some of the medicines are doing right now, and some of the expectations in future clinical trials.

April 14, 2015

CancerTYPE ID in the Clinic

Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.